www.wsj.com/articles/SB108291923112092711

Apr 26, 2004 ... With Aventis succumbing to Sanofi's sweetened offer, the combination of the two will form the world's third-largest pharmaceuticals company, ...

ir.ionispharma.com/news-releases/news-release-details/sanofi-aventis-and-regulus-therapeutics-form-major-strategic

Regulus and sanofi-aventis will collaborate on up to four microRNA targets, including .... Sanofi-aventis, a leading global pharmaceutical company, discovers , ...

www.sanofi.co.za/l/za/en/layout.jsp?scat=514FCFD6-36B3-4764-A5F7-FFB2A26A0940

Sanofi has a diversified offer of prescription medicines, consumer healthcare products, generic medicine, vaccines and animal health products. With the new ...

www.annualreports.com/HostedData/AnnualReportArchive/s/NYSE_SNY_2005.pdf

PHARMACEUTICAL GROUP IN THE WORLD, WE DEVELOP .... available channels YTD at end December 2005: Pharmaceutical market: +6.1%; sanofi- aventis ...

investors.merrimack.com/static-files/1dae0229-4a5d-4a42-b076-ac4d79ffd14b

Oct 1, 2009 ... Under the terms of the agreement, sanofi-aventis will make an upfront payment of $60 million and will be responsible for all development costs.

www.sanofi.es

Hola, somos Sanofi España, la página corporativa de la filial en nuestro país de uno de los principales laboratorios biofarmacéuticos del mundo.

www.thehindubusinessline.com/companies/sanofi-to-buy-universal-medicares-domestic-nutraceuticals-biz/article20327041.ece1

Aug 24, 2011 ... The Sanofi group's Aventis Pharma has formalised an agreement to acquire Universal Medicare Private Ltd's branded nutraceuticals business ...

siteselection.com/ssinsider/bbdeal/bd041025.htm

Oct 25, 2004 ... Sanofi-Aventis' decision on Sept. 24th ensures that all of the more than 3,000 jobs that the former Aventis Pharmaceuticals had in Bridgewater ...

pharmaboardroom.com/directory/sanofi-aventis-france

Jan 6, 2015 ... Sanofi-Aventis provides therapeutic solutions that improve the ... Premiere company in the pharmaceutical industry in France, sanofi-aventis is ...